Synthesis and biological evaluation of imidazolo[2,1-b]benzothiazole derivatives, as potential p53 inhibitors

Michael S. Christodoulou, Francesco Colombo, Daniele Passarella, Gabriella Ieronimo, Valentina Zuco, Michelandrea De Cesare, Franco Zunino

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Since activation of p53 in response to cytotoxic stress may have proapoptotic or protective effects depending on the nature of the injury, inhibitors of p53 may have therapeutic interest as modulators of chemotherapy toxicity or efficacy. In an attempt to identify novel p53 inhibitors, a quality collection of compounds structurally related to pifithrin-β were designed and synthesized as potential inhibitors of p53. The biochemical and biological evaluations supported that compounds of the tetrahydrobenzothiazole series were inhibitors of the p53 transcriptional activity and were effective in enhancing paclitaxel-induced apoptosis. In contrast, in spite of the increased cytotoxic potency, selected compounds of the benzothiazole series were not able to modulate the transcriptional activity of p53, as indicated by lack of change of p21 expression. The therapeutic interest of the compounds of the former series in combination with taxanes was confirmed in a human tumor xenograft model.

Original languageEnglish
Pages (from-to)1649-1657
Number of pages9
JournalBioorganic and Medicinal Chemistry
Volume19
Issue number5
DOIs
Publication statusPublished - Mar 1 2011

Fingerprint

Taxoids
Chemotherapy
Paclitaxel
Heterografts
Modulators
Toxicity
Tumors
Chemical activation
Apoptosis
Derivatives
Drug Therapy
Wounds and Injuries
Therapeutics
Neoplasms
pifithrin
benzothiazole

Keywords

  • Analogues of pifithrin-β
  • Benzothiazole derivatives
  • Biochemical and biological evaluation
  • Combined treatment with taxanes
  • p53 Inhibitors
  • Tetrahydrobenzothiazole derivatives

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Cite this

Christodoulou, M. S., Colombo, F., Passarella, D., Ieronimo, G., Zuco, V., De Cesare, M., & Zunino, F. (2011). Synthesis and biological evaluation of imidazolo[2,1-b]benzothiazole derivatives, as potential p53 inhibitors. Bioorganic and Medicinal Chemistry, 19(5), 1649-1657. https://doi.org/10.1016/j.bmc.2011.01.039

Synthesis and biological evaluation of imidazolo[2,1-b]benzothiazole derivatives, as potential p53 inhibitors. / Christodoulou, Michael S.; Colombo, Francesco; Passarella, Daniele; Ieronimo, Gabriella; Zuco, Valentina; De Cesare, Michelandrea; Zunino, Franco.

In: Bioorganic and Medicinal Chemistry, Vol. 19, No. 5, 01.03.2011, p. 1649-1657.

Research output: Contribution to journalArticle

Christodoulou, MS, Colombo, F, Passarella, D, Ieronimo, G, Zuco, V, De Cesare, M & Zunino, F 2011, 'Synthesis and biological evaluation of imidazolo[2,1-b]benzothiazole derivatives, as potential p53 inhibitors', Bioorganic and Medicinal Chemistry, vol. 19, no. 5, pp. 1649-1657. https://doi.org/10.1016/j.bmc.2011.01.039
Christodoulou, Michael S. ; Colombo, Francesco ; Passarella, Daniele ; Ieronimo, Gabriella ; Zuco, Valentina ; De Cesare, Michelandrea ; Zunino, Franco. / Synthesis and biological evaluation of imidazolo[2,1-b]benzothiazole derivatives, as potential p53 inhibitors. In: Bioorganic and Medicinal Chemistry. 2011 ; Vol. 19, No. 5. pp. 1649-1657.
@article{da2207f825ff487ca56f8277813356f5,
title = "Synthesis and biological evaluation of imidazolo[2,1-b]benzothiazole derivatives, as potential p53 inhibitors",
abstract = "Since activation of p53 in response to cytotoxic stress may have proapoptotic or protective effects depending on the nature of the injury, inhibitors of p53 may have therapeutic interest as modulators of chemotherapy toxicity or efficacy. In an attempt to identify novel p53 inhibitors, a quality collection of compounds structurally related to pifithrin-β were designed and synthesized as potential inhibitors of p53. The biochemical and biological evaluations supported that compounds of the tetrahydrobenzothiazole series were inhibitors of the p53 transcriptional activity and were effective in enhancing paclitaxel-induced apoptosis. In contrast, in spite of the increased cytotoxic potency, selected compounds of the benzothiazole series were not able to modulate the transcriptional activity of p53, as indicated by lack of change of p21 expression. The therapeutic interest of the compounds of the former series in combination with taxanes was confirmed in a human tumor xenograft model.",
keywords = "Analogues of pifithrin-β, Benzothiazole derivatives, Biochemical and biological evaluation, Combined treatment with taxanes, p53 Inhibitors, Tetrahydrobenzothiazole derivatives",
author = "Christodoulou, {Michael S.} and Francesco Colombo and Daniele Passarella and Gabriella Ieronimo and Valentina Zuco and {De Cesare}, Michelandrea and Franco Zunino",
year = "2011",
month = "3",
day = "1",
doi = "10.1016/j.bmc.2011.01.039",
language = "English",
volume = "19",
pages = "1649--1657",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - Synthesis and biological evaluation of imidazolo[2,1-b]benzothiazole derivatives, as potential p53 inhibitors

AU - Christodoulou, Michael S.

AU - Colombo, Francesco

AU - Passarella, Daniele

AU - Ieronimo, Gabriella

AU - Zuco, Valentina

AU - De Cesare, Michelandrea

AU - Zunino, Franco

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Since activation of p53 in response to cytotoxic stress may have proapoptotic or protective effects depending on the nature of the injury, inhibitors of p53 may have therapeutic interest as modulators of chemotherapy toxicity or efficacy. In an attempt to identify novel p53 inhibitors, a quality collection of compounds structurally related to pifithrin-β were designed and synthesized as potential inhibitors of p53. The biochemical and biological evaluations supported that compounds of the tetrahydrobenzothiazole series were inhibitors of the p53 transcriptional activity and were effective in enhancing paclitaxel-induced apoptosis. In contrast, in spite of the increased cytotoxic potency, selected compounds of the benzothiazole series were not able to modulate the transcriptional activity of p53, as indicated by lack of change of p21 expression. The therapeutic interest of the compounds of the former series in combination with taxanes was confirmed in a human tumor xenograft model.

AB - Since activation of p53 in response to cytotoxic stress may have proapoptotic or protective effects depending on the nature of the injury, inhibitors of p53 may have therapeutic interest as modulators of chemotherapy toxicity or efficacy. In an attempt to identify novel p53 inhibitors, a quality collection of compounds structurally related to pifithrin-β were designed and synthesized as potential inhibitors of p53. The biochemical and biological evaluations supported that compounds of the tetrahydrobenzothiazole series were inhibitors of the p53 transcriptional activity and were effective in enhancing paclitaxel-induced apoptosis. In contrast, in spite of the increased cytotoxic potency, selected compounds of the benzothiazole series were not able to modulate the transcriptional activity of p53, as indicated by lack of change of p21 expression. The therapeutic interest of the compounds of the former series in combination with taxanes was confirmed in a human tumor xenograft model.

KW - Analogues of pifithrin-β

KW - Benzothiazole derivatives

KW - Biochemical and biological evaluation

KW - Combined treatment with taxanes

KW - p53 Inhibitors

KW - Tetrahydrobenzothiazole derivatives

UR - http://www.scopus.com/inward/record.url?scp=79952188471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952188471&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2011.01.039

DO - 10.1016/j.bmc.2011.01.039

M3 - Article

VL - 19

SP - 1649

EP - 1657

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 5

ER -